Togu "vilprafen" - ukuba nguye?

Phakathi amayeza nyelwe eqinisekisiweyo kunye neziyobisi "Vilprafen" yaziwa njenge-zintsholongwane ngoweqela amayeza of macrolides, lincosamides kunye streptogramin. It idla esimiselweyo ukulwa usulelo amagciwane, ezo zibangelwa amagciwane sifo. imiphumela bokugcinwa beziyobisi ngempumelelo kwiimeko izifo nokuphefumla phecana kunye lwamazinyo izitshanguba yenkqubo enzala kunye nosulelo dermal izicwili ezithambileyo kunye ancedisana ureaplasmosis gonorrhoea, i-chlamydia kunye negcushuwa mikroplazmoze kunye nosulelo efanayo. Analogue "Vilprafen" - ukulungiselela "clarithromycin" - lisetyenziswa kuphela nje enye.

imiphumela kwemithi

Vilprafen okanye ngamanye amazwi - Josamycin Umsebenzi phezulu nxamnye eziphilayo intracellular, kodwa kunye isahlakalo ukumelana erythromycin akukho wayenga. iziyobisi High zoxinaniso izitshanguba zeethishu na isenzo ecacileyo bactericidal of enterobacteria kwaye siqala ukusebenza encinane. Oku kuthetha ukuba isisu akuthethi ukutshintsha izihluma zendalo virus.

kinetics reception

Ukutya ngokupheleleyo akukuthinteli bioavailability ye iimpawu ichiza. kuba ako lula kwaye zidlula ukusuka phecana zesisu kungena egazini. iiyure Sele ezimbalwa emva nokudla ichiza "Vilprafen" serum eliphezulu ingqalelo kuyaphunyezwa. iiproteni Plasma ukubophelela iimolekyuli dzhosamitsina, eyona nto iphambili esebenzayo beziyobisi, kwaye eyavela ifikelela-15%. Ingakumbi ipesenti ephezulu iqatshelwe tonsils zamaphaphu, isikhohlela, ulwelo lacrimal. Ichiza bangaqokelela emathanjeni, ancedisana secreted ngobisi lwebele emva edlula njengomqobo placental. Nethe dzhosamitsina ukuba okwanamhlanje metabolites esebenzayo esibindini. Isigqibo livela enyongweni. Kukhuthaza nge urethra yi malunga ne-20%.

Dzhosamitsin - icandelo iphambili amayeza "Vilprafen"

Yinto yokuba Dzhosamitsin nguye kuphela kwento ibalulekileyo ekwakhiweni beziyobisi, akakho analog of "vilprafen".

Eyona nto ibalulekileyo khathaza abantu xa uthenga vilprafen - ukuba kwakuhlaziya unyango olubiza kakhulu ukuba ithatha ixesha elide ngaphezu kweentsuku ezili-10. Kwathi ngayo ukuze kuzuzwe isiphumo esemgangathweni kufuneka ngokupheleleyo kwaye ukuthatha iipilisi yonke imihla. "Vilprafen" ne zonke ukubuyekeza ezintle malunga chiza ixabiso eliphezulu ngokwaneleyo, ngoko abantu isoloko ikhangela eqolo nokuba ngokufanayo isifaniso. Ezinye iingcali isindululo njenge analog "vilprafen" iziyobisi "Clarithromycin", kodwa kuphela nje enye.

Fumana Togu "vilprafen" ihamba ezininzi ngakumbi ukuba ukusetyenziswa kwayo akukho akuvumelekanga ukuba abasetyhini abakhulelweyo, oko ingasetyenziswa lwebele oomama, kwaye ikhuselekile kubantwana abancinane. Ngenxa yokungabikho eyaziwa yeziphumo embryotoxic "Vilprafen" ichiza emiselweyo, kuphela nokuhlola ngenyameko ubungozi kunye nezibonelelo zonyango.

Medicine "Vilprafen" kwaye zidityaniswe yayo notywala

IMimiselo ehlonyelwe ichiza, ayiqulathanga naluphi na ebonisa utywala kunye esebenzayo kweziyobisi intsebenziswano dzhosamitsina. Medicine "Vilprafen" kunye notywala - zidityaniswe embi. Umntu onengqondo akufuneki silibale ukuba utywala lisoloko ngamandla isiphumo esibi esibindini - igunya engundoqo elijongene kukhuthaza iziyobisi emzimbeni. Kucingelwa ukuba okunzima of umsebenzi kwesibindi uya kuxhokonxa i flow okuthile duct lokuthathwa utywala ayinqweneleki kakhulu. Izinga avumelekile ngemihla kufika ngaphandle ukuba milligrams 200 utywala nokuba xa kungekho eyandileyo enzyme zesibindi kwi-plasma.